natgillin/translations-raw huggingface dataset:
Based on current experience with the implementation of approved programmes for the eradication of BHV1 infection, direct movement of bovine animals from holdings free of BHV1 infection to enclosed fattening units in Member States or parts thereof which are free of BHV1 infection could be allowed, provided a channelling system is implemented by which the competent authorities at the place of the fattening unit ensure additional testing at arrival and removal of the animals only to the slaughterhouse.
Na podlagi dosedanjih izkušenj z izvajanjem odobrenih programov za izkoreninjenje okužbe z BHV1 se lahko dovoli neposredni premik goveda iz gospodarstev, prostih okužbe z BHV1, v zaprte enote za pitanje v državah članicah ali njihovih delih, prostih okužbe BHV1, če se izvaja sistem usmerjanja, s katerim pristojni organi na območju enote za pitanje zagotovijo dodatno testiranje ob prihodu in samo v primeru prevoza živali v klavnico.
At present, all regions of Germany with the exception of the administrative units of Regierungsbezirke Oberpfalz and Oberfranken in the federal state of Bavaria are listed in Annex I to Decision 2004/558/EC.
Trenutno so v Prilogi I k Odločbi 2004/558/ES navedene vse regije v Nemčiji, razen upravnih enot Regierungsbezirke Oberpfalz (Zgornje Pfalško) in Oberfranken v zvezni deželi Bavarski.
Germany has now submitted documentation in support of its application to declare also the administrative units of Regierungsbezirke Mittelfranken and Unterfranken in the federal state of Bavaria free of BHV1 infection and provided rules for the national movement of bovine animals within and into this part of its territory.
Nemčija je svojemu zahtevku predložila spremno dokumentacijo, s katero je prijavila tudi upravni enoti Regierungsbezirke Oberpfalz (Zgornje Pfalško) in Oberfranken v zvezni deželi Bavarski kot prosti okužbe z BHV1, ter zagotovila pravila za nacionalne premike goveda znotraj svojega ozemlja in v ti dve regiji.
Accordingly, Germany has requested the application of the additional guaranties, in accordance with Article 10 of Directive 64/432/EEC, to be extended to those administrative units in Bavaria.
Zato je Nemčija zahtevala, da se zahtevek za dodatna jamstva v skladu z členom 10 Direktive 64/432/EGS razširi na navedeni upravni enoti na Bavarskem.
Following the evaluation of the application submitted by Germany, it is appropriate that those two BHV1-free administrative units in Germany be no longer listed in Annex I, but be included in Annex II to Decision 2004/558/EC and to extend the application of the additional guaranties established in accordance with Article 10 of Directive 64/432/EEC to them.
Po oceni zahtevka, ki ga je predložila Nemčija, je primerno, da se navedeni nemški upravni enoti, prosti okužbe z BHV1, črtata iz Priloge I in vključita v Prilogo II k Odločbi 2004/558/ES ter da se podaljša veljavnost dodatnih jamstev za ti enoti v skladu s členom 10 Direktive 64/432/EGS.
Decision 2004/558/EC should therefore be amended accordingly.
Odločbo št. 2004/558/ES je zato treba ustrezno spremeniti.
Decision 2004/558/EC is amended as follows:
Odločba 2004/558/ES se spremeni:
Article 2(2)(b)(ii) is replaced by the following:
člen 2(2)(b)(ii) se nadomesti z naslednjim:
they are transported without coming into contact with animals of lesser health status to a holding of unknown BHV1 status in the Member State of destination listed in Annex I, where according to the approved national eradication programme all animals are fattened indoors, and from which they can only be transported to the slaughterhouse;’;
živali so prepeljane na gospodarstvo z neznanim statusom glede BHV1 v namembni državi članici iz Priloge I, tako da ne pridejo v stik z živalmi s slabšim zdravstvenim stanjem, pri čemer so vse živali v skladu z odobrenim nacionalnim programom za izkoreninjenje na tem gospodarstvu pitane v zaprtem prostoru in iz so z njega lahko prepeljane samo v klavnico;“;
after the second indent: “Article 3 paragraph … point … of Commission Decision 2004/558/EC”;’
za drugo alineo: ‚Točka … odstavek … člen 3 Odločbe Komisije 2004/558/ES‘;“;
By way of derogation to paragraph 1(a) and (b), the competent authority in the Member State of destination may authorise the introduction of bovine animals intended for meat production onto a BHV1-free holding as defined in Annex III (BHV1-free holding) situated in a region of that Member State listed in Annex II under the following conditions:
Z odstopanjem od odstavka 1(a) in (b) pristojni organ namembne države članice lahko odobri vnos goveda, namenjenega za proizvodnjo mesa, na gospodarstvo, prosto BVH1, kakor je opredeljeno v Prilogi III (‚gospodarstvo, prosto BHV1‘), v regijah navedene države članice iz Priloge II pod naslednjimi pogoji:
the animals must not have been vaccinated against BHV1 and must originate in and have remained since birth on BHV1-free holdings;
živali ne smejo biti cepljene proti BHV1 ter se morajo skotiti in od skotitve bivati na gospodarstvih, prostih BHV1;
the animals are transported without coming into contact with animals of lesser health status;
živali so prepeljane tako, da ne pridejo v stik z živalmi slabšega zdravstvenega stanja;
for at least 30 days immediately prior to dispatch, or since birth where the animals are less than 30 days old, the animals have remained on the holding of origin, or in an isolation facility approved by the competent authority, which is situated in a Member State in which infectious bovine rhinotracheitis is a compulsorily notifiable disease and in which within an area of 5 km radius around the holding or isolation facility there was no clinical or pathological evidence of BHV1 infection during the past 30 days;
najmanj 30 dni pred odpošiljanjem ali do starosti manj kot 30 dni živali ostanejo na gospodarstvu izvora ali v karanteni, ki jo je odobril pristojni organ v državi članici, v katerih je treba infekciozni bovini rinotraheitis obvezno prijaviti in v premeru 5 km okrog gospodarstva ali karantene v zadnjih 30 dneh ni bil zabeležen noben klinični ali patološki dokaz o okužbi z BHV1;
the animals have been subjected with negative result either to a serological test for antibodies against the gE-glycoprotein of the BHV1 in the case the animals originate from a BHV1 vaccinated herd, or in all other cases to a serological test for antibodies against the entire BHV1 carried out on a sample of blood taken within 7 days prior to dispatch from the holding referred to in point (c);
živali so z negativnimi rezultati opravile bodisi serološki test za odkrivanje protiteles za gE-glikoprotein BHV1, če so živali po poreklu iz črede, cepljene proti BHV1, bodisi v vseh drugih primerih serološki test za odkrivanje protiteles za BHV1 na vzorcu krvi, odvzetem 7 dni pred odpremo z gospodarstva iz točke (c);
on the BHV1-free holding of destination all animals are fattened indoors and are only removed to be transported to the slaughterhouse;
na namembnem gospodarstvu, prostem BHV1, so vse živali pitane v zaprtem prostoru in so z njega premeščene samo v primeru prevoza v klavnico;
the animals referred to in point (d) are subjected to a serological test for antibodies against the gE-glycoprotein of the BHV1 or the entire BHV1 carried out on a sample of blood taken within 21 to 28 days after arrival in the holding referred to in point (e):
na živalih iz točke (d) se opravi serološki test za odkrivanje protiteles za gE-glikoprotein BVH1 ali celoten BHV1 na vzorcu krvi, odvzetem od 21 do 28 dni po prihodu na gospodarstvo iz točke (e);
either with negative result in each case; or
bodisi z negativnimi rezultati v vsakem primeru bodisi
the BHV1-free status of the holding remains suspended until the infected animals have been slaughtered within less than 45 days after arrival on the holding, and
se status gospodarstva, prostega BHV1, začasno prekine, dokler okužene živali niso zaklane v manj kot 45 dneh po prihodu na gospodarstvo, in
either the animals in direct contact with the infected animals have reacted with negative results to a test for antibodies against the gE-glycoprotein of the BHV1 or the entire BHV1 carried out on a sample of blood collected not earlier than 28 days following the removal of the infected animals, or
so živali v neposrednem stiku z okuženimi živalmi z negativnimi rezultati opravile test za odkrivanje protiteles za gE-glikoprotein BHV1 ali celoten BHV1 na vzorcu krvi, odvzetem najmanj 28 dni po odstranitvi okuženih živali, ali
the animals which shared a common airspace with the infected animals have reacted with negative results to a test for antibodies against the entire BHV1 carried out on a sample of blood collected not earlier than 28 days following the removal of the infected animals, or
so živali, ki so dihale isti zrak kot okužene živali, z negativnimi rezultati opravile test za odkrivanje protiteles za BHV1 na vzorcu krvi, odvzetem najmanj 28 dni po odstranitvi okuženih živali, ali
the remaining animals on the holding have reacted with negative results to a test for antibodies against the entire BHV1 carried out on a sample of blood collected not earlier than 28 days following the removal of the infected animals, or
so preostale živali na gospodarstvu z negativnimi rezultati opravile test za odkrivanje protiteles za BHV1 na vzorcu krvi, odvzetem najmanj 28 dni po odstranitvi okuženih živali, ali
the BHV1-free status is restored in accordance with point 4 of Annex III.
se status gospodarstva, prostega BHV1, ponovno vzpostavi v skladu s točko 4 Priloge III.
The Member State of destination referred to in paragraph 4 shall notify to the Commission and to the other Member States the regions listed in Annex II in which the provisions of paragraph 4 are going to be implemented and the date of intended application.’;
Namembne države članice iz odstavka 4 uradno obvestijo Komisijo in druge države članice o regijah iz Priloge II, v katerih se bodo izvajale določbe odstavka 4, in navedejo datum načrtovane uporabe.“;
Annex I is replaced by the text in Annex I to the present Decision;
Priloga I se nadomesti z besedilom iz Priloge I k temu sklepu;
Annex II is replaced by the text in Annex II to the present Decision.
Priloga II se nadomesti z besedilom iz Priloge II k temu sklepu.
Done at Brussels, 5 August 2010.
V Bruslju, 5. avgusta 2010
All regions, except Regierungsbezirke Oberpfalz, Oberfranken, Mittelfranken and Unterfranken in the federal state of Bavaria
Vse regije, razen Regierungsbezirke Oberpfalz (Zgornje Pfalško) ter Oberfranken, Mittelfranken in Unterfranken v zvezni deželi Bavarski
The Autonomous Region of Friuli Venezia Giulia
Avtonomna dežela Furlanija - Julijska krajina
The Autonomous Province of Trento’
Avtonomna pokrajina Trento“
Regierungsbezirke Oberpfalz, Oberfranken, Mittelfranken und Unterfranken in the federal state of Bavaria
Regierungsbezirke Oberpfalz (Zgornje Pfalško) in Oberfranken, Mittelfranken in Unterfranken v zvezni deželi Bavarski
All regions’
Vse regije“
of 6 August 2010
z dne 6. avgusta 2010
amending Annexes I and II to Decision 2008/185/EC as regards the inclusion of Slovenia in the list of Member States free of Aujeszky’s disease and of Poland and regions of Spain in the list of Member States where an approved national control programme for that disease is in place
o spremembi prilog I in II k Odločbi 2008/185/ES glede vključitve Slovenije na seznam držav članic, prostih bolezni Aujeszkega, ter Poljske in regij v Španiji na seznam držav članic, v katerih se izvaja odobreni nacionalni program nadzora za navedeno bolezen
(notified under document C(2010) 5358)
(notificirano pod dokumentarno številko C(2010) 5358)
Directive 64/432/EEC lays down rules applicable to trade in the Union in bovine animals and swine, with the exception of feral pigs.
Direktiva 64/432/EGS določa pravila, ki se v Uniji uporabljajo v trgovini z govedom in prašiči, razen z divjimi prašiči.
Article 9 of that Directive lays down criteria for the approval of compulsory national control programmes for certain contagious diseases, including Aujeszky’s disease.
Člen 9 navedene direktive določa merila za odobritev obveznih nacionalnih programov nadzora za nekatere nalezljive bolezni, vključno z boleznijo Aujeszkega.
In addition, Article 10 of that Directive provides that where a Member State considers its territory or part thereof to be free of such diseases, including Aujeszky’s disease, it is to present appropriate supporting documentation to the Commission.
Poleg tega člen 10 navedene direktive določa, da kadar država članica meni, da je njeno ozemlje ali del njenega ozemlja prost takih bolezni, vključno bolezni Aujeszkega, Komisiji predloži ustrezno spremno dokumentacijo.
Those guarantees are linked to the classification of Member States according to their Aujeszky’s disease status.
Ta jamstva so povezana z razvrstitvijo držav članic glede na njihov status bolezni Aujeszkega.
Annex I to Decision 2008/185/EC lists Member States or regions thereof which are free of Aujeszky’s disease and where vaccination is prohibited.
Priloga I k Odločbi 2008/185/ES navaja države članice ali njihove regije, proste bolezni Aujeszkega, in v katerih je cepljenje prepovedano.
Annex II to that Decision lists Member States or regions thereof where approved national control programmes for the eradication of Aujeszky’s disease are in place.
Priloga II k navedeni odločbi navaja države članice ali njihove regije, v katerih se izvajajo odobreni nacionalni programi nadzora za izkoreninjenje bolezni Aujeszkega.
In Poland and Spain national control programmes for Aujeszky’s disease have been implemented for several years.
Na Poljskem in v Španiji se nacionalni programi nadzora za bolezen Aujeszkega izvajajo že več let.
For several Spanish regions the national control programme for Aujeszky’s disease is already approved by Commission Decision 2007/603/EC [3].
Nacionalni program nadzora za bolezen Aujeszkega je z Odločbo Komisije 2007/603/ES [3] že odobren za več regij v Španiji.
Slovenia has submitted supporting documentation to the Commission as regards the Aujeszky’s disease-free status of the territory of Slovenia demonstrating that the disease has never been detected in that Member State.
Slovenija je Komisiji predložila spremno dokumentacijo, da ima ozemlje Slovenije status območja, prostega bolezni Aujeszkega, z dokazilom, da ta bolezen ni bila nikoli ugotovljena v navedeni državi članici.
The Commission has examined the documentation submitted by Slovenia and found it to comply with the requirements of Article 10(1) of Directive 64/432/EEC.
Komisija je proučila dokumentacijo, ki jo je predložila Slovenija, in ugotovila, da je v skladu z zahtevami iz člena 10(1) Direktive 64/432/EGS.
Accordingly, that Member State should be included in the list set out in Annex I to Decision 2008/185/EC.
Navedeno državo članico je zato treba vključiti na seznam iz Priloge I k Odločbi 2008/185/ES.
Poland has submitted supporting documentation to the Commission as regards the programme in place in the whole territory of Poland and requested the approval of this programme.
Poljska je Komisiji predložila spremno dokumentacijo v zvezi s programom, ki se izvaja na celotnem območju Poljske, ter zaprosila za odobritev tega programa.
Spain has now submitted supporting documentation to the Commission as regards the programme in place in the Autonomous Communities of Andalusia, Aragon, Balearic Islands, Castilla-La Mancha, Catalonia, Extremadura, Madrid, Region of Murcia, Community of Valencia, and the provinces of Salamanca, Segovia and Soria in the Autonomous Community of Castilla y León and the province of Tenerife in the Autonomous Community of the Canary Islands and requested the approval of this programme.
Španija je Komisiji predložila spremno dokumentacijo v zvezi s programom, ki se izvaja v avtonomnih skupnostih Andaluzija, Aragonija, Baleari, Kastilja-La Mancha, Katalonija, Extremadura, Madrid, v regiji Murcia, skupnosti Valencija, v provincah Salamanka, Segovia in Soria v avtonomni skupnosti Kastilja-León ter v provinci Tenerife v avtonomni skupnosti Kanarski otoki ter zaprosila za odobritev tega programa.
The Commission has also found that the national control programmes presented by Poland and Spain comply with the criteria laid down in Article 9(1) of Directive 64/432/EEC.
Komisija je ravno tako ugotovila, da nacionalna programa nadzora, ki sta ju predložili Poljska in Španija, izpolnjujeta merila iz člena 9(1) Direktive 64/432/EGS.
Accordingly, Poland and Spain should be included in the list set out in Annex II to Decision 2008/185/EC.
Poljsko in Španijo je zato treba vključiti na seznam iz Priloge II k Odločbi 2008/185/ES.
Annexes I and II to Decision 2008/185/EC are replaced by the text in the Annex to this Decision.
Prilogi I in II k Odločbi 2008/185/ES se nadomestita z besedilom iz Priloge k temu sklepu.
Done at Brussels, 6 August 2010.
V Bruslju, 6. avgusta 2010
Member States or regions thereof free of Aujeszky’s disease and where vaccination is prohibited
Države članice ali njihove regije, proste bolezni Aujeszkega, in v katerih je cepljenje prepovedano Oznaka ISO
France
Vse regije FR
The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines CY
Francija Departmaji Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Pariz, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines
All regions AT
Vse regije
Finland
Švedska
Sweden All regions UK
Združeno kraljestvo
United Kingdom All regions in England, Scotland and Wales
Vse regije v Angliji, na Škotskem in v Walesu
Member States or regions thereof where approved national control programmes for the eradication of Aujeszky’s disease are in place
Države članice ali njihove regije, v katerih se izvajajo odobreni nacionalni programi nadzora za bolezen Aujeszkega
Ireland
Španija
Spain
Madžarska
The province of Bolzano
Vse regije
Hungary
Italija
All regions in Northern Ireland
Vse regije na Severnem Irskem
Luxembourg
Vse regije
All regions SI Slovenia
Slovenija
of 9 August 2010
z dne 9. avgusta 2010
(notified under document C(2010) 5420)
(notificirano pod dokumentarno številko C(2010) 5420)
Having regard to Council Directive 2003/85/EC of 29 September 2003 on Community measures for the control of foot-and-mouth disease repealing Directive 85/511/EEC and Decisions 89/531/EEC and 91/665/EEC and amending Directive 92/46/EEC [1], and in particular Article 67 thereof,
ob upoštevanju Direktive Sveta 2003/85/ES z dne 29. septembra 2003 o ukrepih Skupnosti za obvladovanje slinavke in parkljevke, ki razveljavlja Direktivo 85/511/EGS in odločbi 89/531/EGS in 91/665/EGS ter spreminja Direktivo 92/46/EGS [1], in zlasti člena 67 Direktive,
Directive 2003/85/EC sets out minimum control measures to be applied in the event of an outbreak of foot-and-mouth disease and certain preventive measures aimed at increasing the awareness and preparedness of the competent authorities and the farming community concerning that disease.
Direktiva 2003/85/ES določa minimalne nadzorne ukrepe, ki jih je treba uporabiti v primeru izbruha slinavke in parkljevke, ter nekatere preventivne ukrepe za boljšo osveščenost in pripravljenost pristojnih organov ter kmetijskega prebivalstva glede zadevne bolezni.
Those preventive measures include an obligation on Member States to ensure that the handling of live foot-and-mouth disease virus for research and diagnosis is carried out only in the approved laboratories listed in Part A and the manufacturing of either inactivated antigens for the production of vaccines or vaccines and related research is carried out only in the approved establishments and laboratories listed in Part B of Annex XI to Directive 2003/85/EC.
V skladu s temi preventivnimi ukrepi so države članice tudi dolžne zagotoviti, da ravnanje z živim virusom slinavke in parkljevke za raziskave in diagnostiko poteka le v odobrenih laboratorijih iz dela A ter da proizvodnja bodisi inaktiviranih antigenov za izdelavo cepiv bodisi cepiv in s tem povezane raziskave potekajo le v odobrenih obratih in laboratorijih iz dela B Priloge XI k Direktivi 2003/85/ES.
Bulgaria has officially informed the Commission that following the checks carried out in accordance with Article 66 of Directive 2003/85/EC, their national reference laboratory is no longer considered to meet the bio-security standards provided for in Article 65(d) of Directive 2003/85/EC.
Bolgarija je uradno obvestila Komisijo, da po pregledih, opravljenih v skladu s členom 66 Direktive 2003/85/ES, njihov referenčni laboratorij več ne izpolnjuje standardov o biovarnosti iz člena 65(d) Direktive 2003/85/ES.
The Netherlands have officially informed the Commission of certain changes relating to the name of a laboratory listed in Part B of Annex XI to Directive 2003/85/EC situated in the Netherlands.
Nizozemska je uradno obvestila Komisijo o določenih spremembah v zvezi z imenom laboratorija iz dela B Priloge XI k Direktivi 2003/85/ES, ki se nahaja na Nizozemskem.
For security reasons, it is important to keep the list of laboratories set out in Annex XI to Directive 2003/85/EC updated.
Iz varnostnih razlogov je pomembno posodabljati seznam laboratorijev iz Priloge XI k Direktivi 2003/85/ES.
Accordingly, it is necessary to delete the entry for Bulgaria in the list of laboratories set out in Part A and to replace the entry for the Netherlands in the list of laboratories set out in Part B of Annex XI to Directive 2003/85/EC.
Zato je treba črtati vnos za Bolgarijo na seznamu laboratorijev iz dela A in nadomestiti vnos za Nizozemsko na seznamu laboratorijev iz dela B Priloge XI k Direktivi 2003/85/ES.
Annex XI to Directive 2003/85/EC should therefore be amended accordingly.
Prilogo XI k Direktivi 2003/85/ES je zato treba ustrezno spremeniti.
Annex XI to Directive 2003/85/EC is amended as follows:
Priloga XI k Direktivi 2003/85/ES se spremeni:
in Part A, the entry for Bulgaria is deleted;
V delu A se vnos za Bolgarijo črta.
Done at Brussels, 9 August 2010.
V Bruslju, 9. avgusta 2010
implementing Council Decision 2000/258/EC as regards proficiency tests for the purposes of maintaining authorisations of laboratories to carry out serological tests to monitor the effectiveness of rabies vaccines
o izvajanju Odločbe Sveta 2000/258/ES glede testiranja strokovne usposobljenosti za namene ohranitve odobritev laboratorijev za izvajanje seroloških testov za nadzorovanje učinkovitosti cepiva proti steklini
(notified under document C(2010) 5421)
(notificirano pod dokumentarno številko C(2010) 5421)